Loading...
Chemical structure of Ibrutinib-MPEA

GC38106

Ibrutinib-MPEA

Also known as (E)-4-[4-(2-aminoethyl)piperazin-1-yl]-1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]but-2-en-1-one

Ibrutinib-MPEA (Compound 20) is ibrutinib derivative· Ibrutinib is a covalent and irreversible inhibitor of Bruton's tyrosine kinase (BTK) that has been used to treat haematological malignancies

ChemicalCAS1710768-30-1MW581.71FormulaC32H39N9O2
CAS number
1710768-30-1
Molecular weight
581.71
Formula
C32H39N9O2
Solubility
Soluble in DMSO
InChIKey
RQQVGXHWCJBNPV-DSCGJTOLSA-N
Catalogue number
GC38106
Brand
GLPBIO
Computed properties PubChem CID 59799011 · XLogP 2.1 · TPSA 132 Ų · H-bond donors 2
XLogP
2.1
TPSA
132 Ų
H-bond donors
2
H-bond acceptors
9
Rotatable bonds
9
Heavy atoms
43

SMILES C1C[C@H](CN(C1)C(=O)/C=C/CN2CCN(CC2)CCN)N3C4=NC=NC(=C4C(=N3)C5=CC=C(C=C5)OC6=CC=CC=C6)N

Computed descriptors from PubChem (CID 59799011), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.